An Open Label Prospective Randomised Study Comparing The Use Of Vincristine, Adriamycin And Cyclophosphamide (VAC) Versus Epirubicin, Cisplatin And Continuous 5-Flourouracil (ECF) In Patients With Unknown Primary Carcinoma (UPC)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cisplatin; Cyclophosphamide; Doxorubicin; Epirubicin; Fluorouracil; Vincristine
- Indications Cancer
- Focus Therapeutic Use
- 20 Sep 2013 Biomarkers information updated
- 27 Sep 2005 New trial record.